SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000318989-17-000041
Filing Date
2017-12-07
Accepted
2017-12-07 17:54:54
Documents
1
Period of Report
2017-12-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 32260
  Complete submission text file 0000318989-17-000041.txt   33990
Mailing Address P.O. BOX H.M. 670 HAMILTON D0 00000
Business Address P.O. BOX H.M. 670 HAMILTON D0 00000 6175637100
FIL Ltd (Reporting) CIK: 0000318989 (see all company filings)

Fiscal Year End: 0630
Type: 3 | Act: 34 | File No.: 001-38311 | Film No.: 171245690

Mailing Address 151 OYSTER POINT BLVD. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Issuer) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)